Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)

WSW, NY, September 3rd, 2026, FinanceWireThe latest filings showing the institutional holdings for Nuvectis Pharma NASDAQ:NVCT appeared a few weeks ago, and for the first time they gave a clear look at who actually put up the money supporting the company's expansion earlier this summer into immunol…